CVS company move to stop selling tobacco products has led to another great loss in the company's sales as they stand to lose approximately 2 billion dollars every year amounting to a 3% loss. Quitting selling tobacco products is one of the reasons why CVS has been unable to provide its tobacco smoking customers with their usual products. The company argues that they are considering a healthy approach that benefits both them and their customers. But with this decision, many of the customers purchasing tobacco products are forced to find alternatives elsewhere or quit smoking altogether.In 2011, CVS had a shortage of several products from Johnson & Johnsons. Consumers were told of the shortages which included Motrin, Pepcid AC, Rolaids, Neutrogena skin care products, children’s Tylenol liquid and Tylenol drugs for adults. A department at Johnsons & Johnsons, the McNeil Consumer Healthcare, recalled millions of the J&J products following a quality control problem in its product lines. Some products were suspected of containing metal while others were reported of having a moldy smell within their bottles. (Natasha & Reed, 2011).Most of the consumer evaluation is positive with many recommending the companys products. One Sheila from Memphis recommended the pharmacy for helping her select the appropriate shampoo for her hair. Another was happy with the results he got when using Monoxildil, a hair growing drug. As much as the company got positive reviews, negative ones were also made. A man who used the same Monoxildil complained of terrible sexual side effects that led him to stop using the product. He is grateful the side effects were not permanent but warns others that even if some side effects were not written down on the box, they really do exist.Supply of some medical products manufactured by Pfizer Inc. had to be recalled. CVS pharmacies supply some of these products. Recalling them meant CVS had to take them off the market. Some of these products were the 30- count Effexor XR 150mg extended release capsules, the 90-count extended release 150mg extended release and the 90-count extended capsule release of 150 mg Greenstone LLC-branded VenlafaxineHC1. The recall took place following a complaint from one of the pharmacies stating that a bottle of Effexor XR from Pfizer contained a capsule of Tikosyn among the Effexor XR capsules.
Consumer Affairs. (2014). Consumer Complaints & Reviews: Top 699 Complaints and Reviews about CVS Pharmacy. Retrieved February 28, 2014 from http://www.consumeraffairs.com/rx/cvs_rx.html
CVS Caremark Company history, (2012). Retrieved from http://info.cvscaremark.com/about-us/our-purpose/company-history
Paul. J. H. Schoemaker (2014). CVS’s Decision to Forgo $2 Billion Seems Crazy, But Just Might Work. Retrieved from http://www.inc.com/author/paul-j-h-schoemaker
Natasha Singer & Reed Abelson (2011). Can Johnson & Johnson Get its Act Together? Retrieved from http://www.nytimes.com/2011/01/16/business/16johnson-and johnson.html?pagewanted=all&_r=0
Institute for Safe Medication Practices (2014). Retrieved from http://www.ismp.org/tools/fdasafetyalerts.asp
Silva, Titus. (2013). Essential Management Skills for Pharmacy and Business Managers. CRC Press.
Please type your essay title, choose your document type, enter your email and we send you essay samples